Adult respiratory distress syndrome - An update

Histopathology

Volumn 34, Issue 4, 1999, Pages 285-294

  Hasleton, P S ^a   Roberts, T E ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Cells; Cytokine; Integrins

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; CELL ADHESION; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG BIOPSY; LUNG EDEMA; PRIORITY JOURNAL; REVIEW;

BLOOD PLATELETS; CELL ADHESION MOLECULES; CYTOKINES; EOSINOPHILS; HUMANS; LUNG; MACROPHAGES; MAST CELLS; NEUTROPHILS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0032944087     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1999.00700.x     Document Type: Review

References (77)

1. 1. Hasleton PS. Adult respiratory distress syndrome: a review. Histopathology 1983; 7; 307-332.
2. 2. Kollef MH, Schuster DP. The acute respiratory distress syndrome. N. Engl. J. Med. 1995; 332; 27-37.
3. 3. Hasleton PS. Adult respiratory distress syndrome. In Hasleton PS ed. Spencer's Pathology of the Lung, 5th edn. New York: McGraw-Hill, 1996: 375-399.
4. 4. Ashbough DC, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2; 319-323.
5. 5. Bone RC. Why new definitions of sepsis and organ failure are needed. Am. J. Med. 1993; 95; 348-350.
6. 6. Byers RJ, Haselton PS, Quigley A, Dennett C, Klapper PE, Cleator GM. Pulmonary herpes simplex in burns patients. Eur. Resp. J. 1996; 9; 2313-2317.
7. 7. Wells S, Sissons M, Hasleton PS. Quantitation of pulmonary megakaryocytes and fibrin thrombi in patients dying from burns. Histopathology 1984; 8; 517-527.
8. 8. Stanley MW, Henry-Stanley MJ. Cmic MS, Gajl-Peczalsk KJ, Bitterman PM. Hyperplasia of type II pneumocytes in acute lung injury: cytologic findings in sequential bronchoalveolar lavage. Am. J. Clin. Pathol. 1992; 97; 669-677.
9. 9. Eppler GR, Colby TV. A spectrum of bronchiolitis obliterans. Chest 1983; 83; 161-162.
10. 10. Corrin B. Lung pathology in septic shock. J. Clin. Pathol. 1980; 33; 891-894.
11. 11. Tate RM, Repine JE. Neutrophil and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1983; 125; 552-559.
12. 12. Tetley TD. Proteinase imbalance: its role in lung diseuse. Thorax 1993; 48; 560-565.
13. 13. Glauser FL, Fairman RP. The uncertain role of the neutrophil polymorph in increased permeability pulmonary edema. Chest 1985; 88; 601-607.
14. 14. Laufe MD, Simon RH, Flint A, Keller JB. Adult respiratory distress syndrome in neutropenic patients. Am. J. Med. 1986; 80; 1022-1025.
15. 15. Ongibene FP, Martin SE, Parker MM et al. Adult respiratory distress syndrome in severe neutropenia. N. Engl. J. Med. 1986; 315; 547-551.
16. 16. Chollet-Martin S, Montravers P, Jibert C et al. Subpopulation of hyperresponsive polymorphonuclear neutrophils in patients with adult respiratory distress syndrome: role of cytokine production. Am. Rev. Respir. Dis. 1992; 146; 990-996.
17. 17. Lee CT, Fein AM, Lippmann M, Holtzman H, Kimbel P, Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with Adult Respiratory Distress Syndrome. N. Engl. J. Med. 1991; 304; 192-196.
18. 18. Hallgren R, Samuelson T, Veng P, Modig J. Eosinophil activation in the lung is related to lung damage in adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1987; 135; 639-642.
19. 19. Heath D, Trueman T, Sukontharmarn P. Pulmonary mast cells in mitral stenosis. Cardiovasc. Res. 1969; 3; 467-471.
20. 20. Lieber JM, Qu Z, Buckner B, Powers MR, Rosenbaum JT. Fibroproliferation and mast cells in the acute respiratory distress syndrome. Thorax 1998; 53; 823-829.
21. 21. Heffner JE, Sahn SA, Repine JE. The role of platelets in adult respiratory distress syndrome: a culprit or bystander. Am. Rev. Respir. Dis. 1987; 135; 482-492.
22. 22. Nicod LP. Cytokines: overview. Thorax 1993; 48; 660-667.
23. 23. Martinet Y, Menard O, Vaillant P, Vignaud J-M, Martinet N. Cytokines in lung librosis. Arch. Toxicol. Suppl. 1996; 18; 127-139.
24. 24. Cohen MC, Cohen S. Cytokine function: a study in biologic diversity. Am. J. Clin. Pathol. Suppl. 1996; 105; 589-597.
25. 25. Lufter AD. Chemokines-chemotactic cytokines that mediate information. N. Engl. J. Med. 1998; 338; 436-445.
26. 26. Carswell EA, Old LJ, Kassel RL et al. An endotoxin-induced serum factor that causes necrosis of tumours. Proc. Natl. Acad. Sci. 1975; 72; 3666-3670.
27. 27. Spive ST, Morion CC, Nedospafov FA, Fiers W, Pious D, Strominger JL. Genes for the tumour factors alpha and beta are linked to the major histocompatibility complex. Proc. Natl. Acad. Sci. USA 1986; 83; 8699-8702.
28. 28. Vassalli P. Pathophysiology of tumour necrosis factors. Am. Rev. Immunol. 1992; 10; 411-452.
29. 29. Van Poll T, Lowry SF. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defence. Shock 1995; 3; 1-12.
30. 30. Pugin J. Ricou B, Steinberg KP, Suter PM, Martin TR. Pro-inflammatory activity in bronchoalveolar lluid in patients with ARDS, a prominent role for IL-1. Am. J. Respir. Crit. Care Med. 1996; 153; 1850-1856.
31. 31. Windsor AC, Walsh CJ, Mullen PG et al. Tumour necrosis factor-alpha blockade prevent neutrophil CD18 receptor upregulalion and attenuates acute lung in porcine sepsis without inhibition of neutrophil oxygen radical generation. J. Clin. Invest. 1993; 91; 1459-1468.
32. 32. Bonsignore MR, Valenti A, Spatofora A. Tumour factor-alpha does not cause lung edema in rabbits. J. Appl. Physiol. 1992; 773; 173-178.
33. 33. Fisher CJ, Agosti JM, Opal SM et al. Treatment of septic shock with tumour necrosis factor receptor: Fc fusion protein. N. Engl. J. Med. 1996; 334; 1697-1702.
34. 34. Gordon HM, Kuchera G, Salvo R et al. TNF induces genes involved in inflammation, cellular and tissue repair and metabolism in murine fibroblasts. J. Immnol. 1992; 148; 4021-4027.
35. 35. Azzawi M, Hasleton PS. TNF-alpha and the cardiovascular system: its role in cardiac allograft rejection and heart disease. Cardiovasc. Dis. (in press).
36. 36. Mann DL. The effect of TNF alpha on cardiac structure and function: a tale of two cytokines. J. Cardiac Failure 1996; 2; S165-S172.
37. 37. Rahman I, McNee W. Role of transcription factors in inflammatory lung diseases. Thorax 1998; 53; 601-612.
38. 38. Thompson AB, Robbins RA, Romberger DJ et al. Immunological functions of the pulmonary epithelium. Eur Respir J. 1985; 8; 127-149.
39. 39. Blackwell TS, Christman JW. The role of nuclear factor Kappa beta in cytokine gene regulation. Am. J. Respir. Mol. Biol. 1997; 17; 3-9.
40. 40. Hiers TM, Trichomi SM, Dettenmeier PA, Fowler AA. Tumour necrosis factor levels in serum and bronchoalveolar lavage fluid in patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1991; 144; 268-271.
41. 41. Parsons PE, Moore FA, Moore EE, Ikle DN, Henson PM, Worthen GS. Studies of tumor necrosis factor in adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1992; 146; 694-700.
42. 42. Armstrong L, Millar B. Relative production of tumour necrosis factor alpha and interleukin-10 in adult respiratory distress syndrome. Thorax 1997; 52; 442-446.
43. 43. Nash JRG, McLaughlin PJ, Hoyle C, Roberts D. Immunolocalisation of tumour necrosis factor alpha in lung tissue from patients dying from adult respiratory distress syndrome. Histopathology 1991; 19; 395-402.
44. 44. Wilcox PG, Wakai Y, Walley KR, Cooper DJ, Road J. Tumor necrosis factor alpha decreases in vivo contractivity in dogs. Am. J. Crit. Care Med. 1994; 150; 1368-1373.
45. 45. Attifano L, Rana JL, Lopez-Casillas F et al. TGF-beta receptors and actions. Biochim. Biophys. Acta 1994; 1222; 78-80.
46. 46. Beck LS, DeGuzman L. Lee WP et al. One systemic administration of transforming growth factor-beta 1 reverses age-or glucocorticoid-impaired wound healing. J. Clin. Invest. 1993; 92; 2841-2849.
47. 47. Derynck R, Lindquist PB, Lee A et al. A new type of transforming factor-beta, TGF beta 3. EMBO J. 1988; 7; 3737-3743.
48. 48. El-Gamel A, Awad M, Sim E et al. Transforming growth factor beta 1 and lung fibrosis. Eur. J. Cardiothorac. Surg. 1998; 30; 424-430.
49. 49. McAnulty RJ, Laurent GI. Pathogenesis of lung fibrosis and potential new therapeutic strategies. Exp. Nephrol. 1995; 3; 96-107.
50. 50. Kullmann A, Vaillant P. Muller V, Martinet Y, Martinet N. In vitro effects of pentoxifylline on smooth muscle cell migration and blood monocyte production of chemotactic activity for smooth muscle cells: potential therapeutic benefit in the adult respiratory distress syndrome. Am. J. Resip. Cell Mol. Biol. 1993; 8; 83-88.
51. 51. Dinarello C, Wolff SM. The role of interleukin-1 in disease. N. Engl. J. Med. 1993; 328; 106-113.
52. 52. Moser R, Scleiffenbaum B, Groscurth P, Fehr J. Interleukin-1 and tumour necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J. Clin. Invest. 1989; 83; 444-455.
53. 53. Baggiolini M, Walz A, Kunkel SL. Neutrophil activating peptide-1/ interleukin-8, a novel cytokine that activates neutrophils. J. Clin. Invest. 1989; 84; 1045-1049.
54. 54. Standiford TJ, Kunkel SL, Phan H, Rollins BJ, Stricter RM. Alveolar macrophage-derived cytokine induce monocyte chemoattractant protein-1 expression from human type II-like epithelial cells. J. Biol. Chem. 1996; 154; 602-611.
55. 55. Sandiford TJ, Rolfe MW, Kunkel SL et al. Macrophage inflammatory protein-1 expression in interstitial lung disease. J. Immunol. 1993; 151; 2852-2863.
56. 56. Goodman RB, Stricter RM, Martin DP et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1996; 154; 602-611.
57. 57. Johnson JL, Moore EE, Tamura DY, Zallen G, Biffl WL, Silliman CC. Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J. Surg. Res. 1998; 76; 91-94.
58. 58. Donnelly SC, Stricter RM, Kunkel SL et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341; 643-647.
59. 59. Folkosson HG, Matthew MA. Hebert CA. Broaddus VC. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8 dependent mechanisms. J. Clin. Invest. 1995; 96; 107-116.
60. 60. Miller EJ, Cohen AB, Matthay MA. Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome. Crit. Care Med. 1996; 24; 1448-1454.
61. 61. Goodman RB, Stricter RM, Steinberg KP et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1996; 154; 602-611.
62. 62. Arai KL, Lee F, Miyajima A, Miyatake S. Arai N, Yokota T. Cytokines: coordinators of immune and inflammatory responses. Ann. Rev. Biochem. 1990; 353; 68-71.
63. 63. Baumhofer JM, Beinhauer HG, Wang JE et al. Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence. Eur. J. Immunol. 1998; 2; 610-615.
64. 64. Howard M, O'Garra A. Biological properties of interkeukin 10. Immunol. Today 1992; 13; 198.
65. 65. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J. Exp. Med. 1991; 174; 1549.
66. 66. Donnelly SC, Stricter RA, Reid PT et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with adult respiratory distress syndrome. Ann. Intern. Med. 1996; 125; 191-196.
67. 67. Nicoletti F, Mancuso G. Cusumano V et al. Prevention of endotoxin-induced lethalitty in neonatal mice by interleukin-13. Eur. J. Immunol. 1997; 6; 1580-1583.
68. 68. Muchamuel T, Menon S, Pisacane P, Howard MC, Cockayne DA. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma and IL-12 production. J. Immunol. 1997; 158; 2898-2903.
69. 69. Spertini O, Luscinskas FW, Munro JM et al. Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion and transmigration. J. Immunol. 1991; 147; 2565-2573.
70. 70. Schleiffenbaum B, Spertinin O, Tedder TF. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J. Cell Biol. 1992; 119; 229-238.
71. 71. Bevilacqua MP, Nelson RM. Selectins. J. Clin. Invest. 1973; 91; 379.
72. 72. Donnelly SC, Haslett C, Dransfield I et al. Role of selectins in development of adult respiratory distress syndrome. Lancet 1994; 344; 215-219.
73. 73. Bevilacqua MP, Pober JS, Mendrick DL et al. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. 1987; 84; 9238.
74. 74. Lewisohn DN, Bargatze RF, Butcher EC. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes and other leukocytes. J. Immunol. 1987; 138; 4313.
75. 75. Schleiffenbaum B, Spertini O, Tedder TF. Soluble L-selectin is present in plasma at high levels and retains functional activity. J. Cell Biol. 1992; 119; 229.
76. 76. Sessler CN, Bloomfield GL, Fowler AA. Three current concepts of sepsis and acute lung injury. Clin. Chest Med. 1996; 17; 215-235.
77. 77. Bone RC. Why sepsis trial fail. JAMA 1996; 276; 565-566.